Business profile
Loading canonical business information.
About
Services
Products
Articles & research
Offers
Published by the business. Confirm current availability and terms with the business.
Browse productsPromotions
Published by the business. Confirm current availability and terms with the business.
Browse productsFrequently asked questions
Answers published by the business.
Published agent capabilities
Capabilities recorded in this listing. Their presence is not a live availability check.
AI-readable discovery
Read the structured business information and inspect the published discovery documents.
Machine-readable documents do not by themselves establish a live AI agent, checkout or business ownership.
Request a quote
Loading quote availabilityβ¦
Sources
Report this listing
Tell us what needs reviewing. Removal requests are reviewed before any change is made.
Request removalProfile information
Publication, owner access and business registry verification are separate. Verification badges describe the checks completed; public references identify this listing.
Structured public business summary
Eyenuk
EyeArt autonomous AI detects vision-threatening diabetic retinopathy in seconds. FDA 510(k)-cleared technology enabling non-invasive retinal screening at the point of care with 96-97% sensitivity.
United States
Business nature
- Primary business nature
- Not provided
- Customer market
- Not provided
Operating hours
Hours not provided.
Categories
- Other Businesses & Services (primary)
Services
- Advanced Grading Tools β Specialized clinical workspace with progressive analysis capabilities for manual disease progression tracking
- Autonomous DR Detection (mtmDR and vtDR) β Real-time detection of more than mild and vision-threatening diabetic retinopathy
- Care Coordination β Automated EHR sync and prioritized specialist referral routing
- Clinical Triage and Expert Review β Intelligent clinical triage and expert review powered by EyeArt and EyeScreen. Automatically prioritize vision-threatening pathology and resolve inconclusive cases with integrated specialist validation.
- Compliance and Audit Readiness β Standardized records supporting accurate risk adjustment and quality compliance goals
- Diabetic Retinopathy Screening β FDA-cleared autonomous AI for diabetic retinopathy screening powered by EyeArt. Detect more than mild and vision-threatening DR in seconds at the point of care without requiring a specialist.
- EHR Integration β Direct sync to patient EHR for specialist referral coordination
- Expert Human Review β Resolve ungradable images and inconclusive cases with centralized human grader validation
- Longitudinal Comparison β Compare previous findings with recent encounters to identify subtle changes in ocular and systemic health
- Longitudinal Disease Monitoring and Specialist Review β A lifelong commitment to vision and systemic health. Utilize comprehensive findings and advanced grading tools to support specialist review over time and strengthen continuity of patient care.
- Multi-Camera Compatibility β Compatible with leading retinal camera manufacturers including Canon and Topcon
- Multi-Condition Detection β Detect and flag DR, AMD, and GOND findings for comprehensive pathology identification
- Network-Wide Reporting β On-demand dashboards monitoring screening volumes and pathology trends across clinical locations
- Objective Risk Stratification β Automatically categorize exams by severity and flag high-risk pathology for urgent intervention
- Program Compliance β Audit-ready records and centralized visibility for quality metrics
- Systemic Health Insights β Non-invasive retinal imaging for early detection of systemic vascular and neural health risks
Service areas
- United States
Public contacts
- Public email: info@eyenuk.com
- Public phone: +1 818 835 3585
- dk: https://dk.linkedin.com/in/madsdall
- linkedin: https://www.linkedin.com/company/eyenuk-llc/
- linkedin: https://www.linkedin.com/in/agarwalgr
- linkedin: https://www.linkedin.com/in/chaithanya-ramachandra-4109305a
- linkedin: https://www.linkedin.com/in/sandeepkbhat
- linkedin: https://www.linkedin.com/in/malavika-b-aba1691
- linkedin: https://www.linkedin.com/in/greg-russell-b7799b57
- linkedin: https://www.linkedin.com/in/ksolanki
- linkedin: https://www.linkedin.com/in/marielouiselittle
- uk: https://uk.linkedin.com/in/zina-affas-besse-phd-2396058
Declared AI capabilities
- Online support β Detected from public website navigation or discovery metadata.
Directory status
Registry verification: Not Registry Verified
Directory score: 95
Public source evidence
- Eyenuk | FDA-Cleared Autonomous AI Screening for Diabetic Retinopathy
- Autonomous AI Eye Screening Resources & Insights | Eyenuk
- Contact Eyenuk | Leaders in Autonomous AI Eye Screening
- About Eyenuk | Leaders in Autonomous AI Eye Screening
- AI-Enabled Ophthalmic Disease Monitoring | Eyenuk
- Autonomous AI Eye Screening Solutions for Diabetic Retinopathy | Eyenuk
- AI Triage Solutions for Diabetic Eye Disease | Eyenuk
- AI-Powered Eye Screening & Diagnostic Solutions | Eyenuk